Clinical Trial Update: A Clinical Trial of Tolcapone in Obsessive Compulsive Disorder [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating tolcapone for obsessive-compulsive disorder is active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obsessive-compulsive Disorder

Drugs mentioned

• Tolcapone (tolcapone)

Snippet

Sponsor: University of Chicago | Conditions: Obsessive-Compulsive Disorder, OCD | Phase 2 | Status: ACTIVE_NOT_RECRUITING